Protalix Biotherapeutics, Inc.
PLX
Revenue
17.85M
▲2.19M▲14.01%
3 Months ChangeAssets
82.26M
▲3.78M▲4.81%
3 Months ChangeLiabilities
29.36M
▲773.00k▲2.70%
3 Months ChangeFree Cash Flow
-5.36M
▼-8.95M▼-249.42%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001104659-26-024975
2026-02-11
Form 8-K
ID: 0001104659-26-013498
2026-01-30
Form 8-K
ID: 0001104659-26-008410
2026-01-05
Form 8-K
ID: 0001104659-26-000393
2025-11-13
Form 10-Q
ID: 0001104659-25-110824
2025-11-13
Form 8-K
ID: 0001104659-25-110821
2025-11-03
Form 8-K
ID: 0001104659-25-105594
2025-10-17
Form 8-K
ID: 0001104659-25-100264
2025-08-22
Form 8-K
ID: 0001104659-25-081924
2025-08-14
Form 10-Q
ID: 0001558370-25-011471